Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.17 USD | +1.98% |
|
+1.98% | +1.98% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 1T | A | ||||||||
| 613B | BBB | ||||||||
| 433B | AA | - | |||||||
| 350B | AA | ||||||||
| 292B | AAA | ||||||||
| 239B | A | ||||||||
| 206B | A | ||||||||
| 204B | A | ||||||||
| 163B | AA | ||||||||
| 143B | A | ||||||||
| 134B | A | ||||||||
| 119B | AA | ||||||||
| 103B | AA | ||||||||
| 103B | AA | ||||||||
| 70.18B | AA | ||||||||
| 55.08B | AA | ||||||||
| 53.26B | AA | ||||||||
| 51.77B | AA | ||||||||
| 42.85B | AA | ||||||||
| Average | 230.26B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
















